ColonCAD Cleared by FDA

Article

Medicsight now has FDA 510(k) clearance to market ColonCAD, a computer-aided detection system to aid in CT colonography.

Medicsight now has FDA 510(k) clearance to market ColonCAD, a computer-aided detection system to aid in CT colonography.

The system uses an algorithm to review data and highlight potential polyps in virtual colonoscopies.

The FDA decision was supported by a clinical trial in which 15 radiologists reviewed 112 CT colonography cases assisted and unassisted by ColonCAD. Reviews using the system showed greater accuracy.

Use of virtual colonoscopy is increasing in the US, despite question about payment.

 

 

 

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.